- Home
- QTTB vs TC Comparison
QTTB vs TC Comparison
Compare QTTB & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTTB
- TC
- Stock Information
- Founded
- QTTB 2015
- TC 2010
- Country
- QTTB United States
- TC China
- Employees
- QTTB N/A
- TC N/A
- Industry
- QTTB Biotechnology: Pharmaceutical Preparations
- TC Business Services
- Sector
- QTTB Health Care
- TC Consumer Discretionary
- Exchange
- QTTB Nasdaq
- TC Nasdaq
- Market Cap
- QTTB 23.3M
- TC 25.0M
- IPO Year
- QTTB N/A
- TC 2018
- Fundamental
- Price
- QTTB $2.19
- TC $13.26
- Analyst Decision
- QTTB Hold
- TC
- Analyst Count
- QTTB 7
- TC 0
- Target Price
- QTTB $12.17
- TC N/A
- AVG Volume (30 Days)
- QTTB 65.7K
- TC 30.8K
- Earning Date
- QTTB 11-06-2025
- TC 12-16-2025
- Dividend Yield
- QTTB N/A
- TC N/A
- EPS Growth
- QTTB N/A
- TC N/A
- EPS
- QTTB N/A
- TC N/A
- Revenue
- QTTB N/A
- TC $5,115,721.00
- Revenue This Year
- QTTB N/A
- TC N/A
- Revenue Next Year
- QTTB N/A
- TC N/A
- P/E Ratio
- QTTB N/A
- TC N/A
- Revenue Growth
- QTTB N/A
- TC N/A
- 52 Week Low
- QTTB $1.35
- TC $9.20
- 52 Week High
- QTTB $53.17
- TC $86.00
- Technical
- Relative Strength Index (RSI)
- QTTB 69.18
- TC 63.15
- Support Level
- QTTB $1.79
- TC $12.72
- Resistance Level
- QTTB $2.11
- TC $14.13
- Average True Range (ATR)
- QTTB 0.14
- TC 1.19
- MACD
- QTTB 0.04
- TC -0.53
- Stochastic Oscillator
- QTTB 81.82
- TC 22.98
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.